Morrow, Gael BCarlier, Molly S ADasgupta, SrutiCraigen, Fiona BMutch, Nicola JCurry, Nicola2021-02-242021-02-242021-02-22Morrow, G B, Carlier, M S A, Dasgupta, S, Craigen, F B, Mutch, N J & Curry, N 2021, 'Fibrinogen Replacement Therapy for Traumatic Coagulopathy : Does the Fibrinogen Source Matter?', International Journal of Molecular Sciences, vol. 22, no. 4, 2185. https://doi.org/10.3390/ijms220421851422-0067Bibtex: ijms22042185PubMedCentral: PMC7926643ORCID: /0000-0001-9299-6754/work/116417848ORCID: /0000-0002-6917-3917/work/127817700ORCID: /0000-0002-7452-0813/work/169538872https://hdl.handle.net/2164/15919Funding: This work was supported by an NIHR programme grant for applied research; PGfAR01590; “Traumatic coagulopathy and massive transfusion: improving outcomes and saving blood”.151348513engBlood Coagulation Disorders/etiologyCoagulants/administration & dosageDose-Response Relationship, DrugFactor VIII/therapeutic useFibrinogen/administration & dosageFibrinolysisHemorrhage/complicationsHumansMicroscopy, ConfocalThrombelastographyThrombin/metabolismThrombosis/chemically inducedfibrinogencryoprecipitatetrauma coagulopathy2‐antiplasmin/α2‐antiplasminFactor XIIIR MedicineMolecular BiologySpectroscopyCatalysisInorganic ChemistryComputer Science ApplicationsPhysical and Theoretical ChemistryOrganic ChemistryRJournal article10.3390/ijms22042185http://www.scopus.com/inward/record.url?scp=85100912175&partnerID=8YFLogxK224